AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today ...
There’s a boom coming. Bitcoin has arrived, and its price is setting records. Artificial intelligence is hot. And the American people just elected a president with a deregulatory mindset.